Al-Asiri S,Basit S,Wood-Trageser MA,Yatsenko SA,Jeffries EP,Surti U,Ketterer DM,Afzal S,Ramzan K,Faiyaz-Ul Haque M,Jiang H,Trakselis MA,Rajkovic A .2015 .Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J. Clin. Invest, 125(1) : 258-262.
Anna A,Monika G .2018 .Splicing mutations in human genetic disorders: Examples, detection and confirmation. J. Appl. Genet, 59(3) : 253-268.
Baccarani M,Deininger MW,Rosti G,Hochhaus A,Soverini S,Apperley JF,Cervantes F,Clark RE,Cortes JE,Guilhot F,Hjorth-Hansen H,Hughes TP,Kantarjian HM,Kim DW,Larson RA,Lipton JH,Mahon FX,Martinelli G,Mayer J,Müller MC,Niederwieser D,Pane F,Radich JP,Rousselot P,Saglio G,Saußele S,Schiffer C,Silver R,Simonsson B,Steegmann JL,Goldman JM,Hehlmann R JM .2013 .European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood, 122(6) : 872-884.
Bogliolo M,Cabre O,Callén E,Castillo V,Creus A,Marcos R,Surralles J .2002 .The Fanconi anaemia genome stability and tumour suppressor network. Mutagenesis, 17(6) : 529-538.
Borriello A,Locasciulli A,Bianco AM,Criscuolo M,Conti V,Grammatico P,Cappellacci S,Zatterale A,Morgese F,Cucciolla V,Delia D,Della Ragione F,Savoia A .2007 .A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia. Leukemia, 21(1) : 72-78.
Branford S,Kim DDH,Apperley JF,Eide CA,Mustjoki S,Ong ST,Nteliopoulos G,Ernst T,Chuah C,Gambacorti-Passerini C,Mauro MJ,Druker BJ,Kim DW,Mahon FX,Cortes J,Radich JP,Hochhaus A,Hughes TP .2019 .International CML Foundation Genomics Alliance. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia. Leukemia, 33(8) : 1835-1850.
Cagnan I,Gunel-Ozcan A,Aerts-Kaya F,Ameziane N,Kuskonmaz B,Dorsman J,Gumruk F,Uckan D F .2018 .Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production. Rev. Rep, 14(3) : 425-437.
Chandrasekharappa SC,Chinn SB,Donovan FX,Chowdhury NI,Kamat A,Adeyemo AA,Thomas JW,Vemulapalli M,Hussey CS,Reid HH,Mullikin JC,Wei Q,Sturgis EM,Cancer EM .2017 .Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. , 123(20) : 3943-3954.
Chandrasekharappa SC,Lach FP,Kimble DC,Kamat A,Teer JK,Donovan FX,Flynn E,Sen SK,Thongthip S,Sanborn E,Smogorzewska A,Auerbach AD,Ostrander EA .2013 .NISC Comparative Sequencing Program. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood, 121(22) : e138-48.
Chang L,Yuan W,Zeng H,Zhou Q,Wei W,Zhou J,Li M,Wang X,Xu M,Yang F,Yang Y,Cheng T,Zhu X .2014 .Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients. BMC, Med, 15(7) : 24.
Cortes J,Radich J,Mauro MJ J .2012 .Clinical roundtable monograph: Emerging treatment options for TKI-resistant chronic myelogenous leukemia. Clin. Adv. Hematol. Oncol., 10(10 Suppl 19) : 1-16.
Daley GQ,Van Etten RA,Baltimore D .1990 .Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science, 247(4944) : 824-830.
D'Andrea AD,Grompe M .2003 .The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer, 3(1) : 23-34.
Druker BJ,Guilhot F,O'Brien SG,Gathmann I,Kantarjian H,Gattermann N,Deininger MW,Silver RT,Goldman JM,Stone RM,Cervantes F,Hochhaus A,Powell BL,Gabrilove JL,Rousselot P,Reiffers J,Cornelissen JJ,Hughes T,Agis H,Fischer T,Verhoef G,Shepherd J,Saglio G,Gratwohl A,Nielsen JL,Radich JP,Simonsson B,Taylor K,Baccarani M,So C,Letvak L,Larson RA .2006 .Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med, 355(23) : 2408-2417.
Faraoni I,Aloisio F,De Gabrieli A,Consalvo MI,Lavorgna S,Voso MT,Lo-Coco F,Graziani G F .2018 .The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation. , 423(1) : 127-138.
Garcia MJ,Benitez J .2008 .The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets. Clin. Transl, 10(2) : 78-84.
Haznedaroglu IC .2013 .Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European Leukemia Net recommendations. , 14(15) : 2005-10.
Hiroki H,Ishi Y,Piao J,Morio T .2019 .PARP Inhibition Sensitize BCR-ABL1 Positive Cel. , 134 : 3367.
Kalb R,Neveling K,Hoehn H,Schneider H,Linka Y,Batish SD,Hunt C,Berwick M,Callen E,Surralles J,Casado JA,Bueren J,Dasi A,Soulier J,Gluckman E,Zwaan CM,van Spaendonk R,Pals G,de Winter JP,Joenje H,Grompe M,Auerbach AD,Hanenberg H,Schindler D H .2007 .Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am. J. Hum. Genet, 80(5) : 895-910.
Kanchi KL,Johnson KJ,Lu C,McLellan MD,Leiserson MD,Wendl MC,Zhang Q,Koboldt DC,Xie M,Kandoth C,McMichael JF,Wyczalkowski MA,Larson DE,Schmidt HK,Miller CA,Fulton RS,Spellman PT,Mardis ER,Druley TE,Graubert TA,Goodfellow PJ,Raphael BJ,Wilson RK,Ding L RK .2014 .Integrated analysis of germline and somatic variants in ovarian cancer. Nat. Commun, 5(1) : 3156.
Kim T,Tyndel MS,Zhang Z,Ahn J,Choi S,Szardenings M,Lipton JH,Kim HJ,Kim Dong Hwan D HJ .2017 .Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy. Leuk. Res., 59(1) : 142-148.
Knies K,Schuster B,Ameziane N,Rooimans M,Bettecken T,de Winter T,Schindler D T .2012 .Genotyping of fanconi anemia patients by whole exome sequencing: advantages and challenges. PLoS, 7(12) : e52648.
Koptyra M,Stoklosa T,Hoser G,Glodkowska-Mrowka E,Seferynska I,Klejman A,Blasiak J,Skorski T .2011 .Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinaseinduced leukemogenesis. Leukemia, 25(8) : 1259-67.
Liu Y,Song H,Song H,Feng X,Zhou C,Huo Z C .2019 .Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia. AMB, 159(1) : 108.
Lyakhovich A,Surralles J .2006 .Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer. Cancer, 232(1) : 99-106.
Maxwell KN,Hart SN,Vijai J,Schrader KA,Slavin TP,Thomas T,Wubbenhorst B,Ravichandran V,Moore RM,Hu C,Guidugli L,Wenz B,Domchek SM,Robson ME,Szabo C,Neuhausen SL,Weitzel JN,Offit K,Couch FJ,Nathanson KL .2016 .Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and NonCancer-Associated Genes in Families Affected by Breast Cancer. Am. J. Hum. Genet, 98(5) : 801-817.
Nalepa G,Clapp DW .2018 .Fanconi anaemia and cancer: An intricate relationship. Nat. Rev. Cancer, 18(3) : 168-85.
Paulo P,Maia S,Pinto C,Pinto P,Monteiro A,Peixoto A,Teixeira MR .2018 .Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer. PLoS, 14(4) : e1007355.
Quintás-Cardama A,Cortes J .2009 .Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood, 113(8) : 1619-1630.
Retterer K,Juusola J,Cho MT,Vitazka P,Millan F,Gibellini F,Vertino-Bell A,Smaoui N,Neidich J,Monaghan KG,McKnight D,Bai R,Suchy S,Friedman B,Tahiliani J,Pineda-Alvarez D,Richard G,Brandt T,Haverfield E,Chung WK,Bale S WK .2016 .Clinical application of whole-exome sequencing across clinical indications. Genet. Med, 18(7) : 696-704.
Smith CG,Naven M,Harris R,Colley J,West H,Li N,Liu Y,Adams R,Maughan TS,Nichols L,Kaplan R,Wagner MJ,McLeod HL,Cheadle JP .2013 .Exome resequencing identifies potential tumorsuppressor genes that predispose to colorectal cancer. Hum, 34(7) : 1026-1034.
Thompson ER,Doyle MA,Ryland GL,Rowley SM,Choong DY,Tothill RW,Thorne H,Barnes DR,Li J,Ellul J,Philip GK,Antill YC,James PA,Trainer AH,Campbell IG AH .2012 .Exome equencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS, 8(9) : e1002894.
Timmers C,Taniguchi T,Hejna J,Reifsteck C,Lucas L,Bruun D,Thayer M,Cox B,Olson S,D'Andrea AD,Moses R,Grompe M .2001 .Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell, 7(2) : 241-8.
Togasaki E,Takeda J,Yoshida K,Shiozawa Y,Takeuchi M,Oshima M,Saraya A,Iwama A,Yokote K,Sakaida E,Hirase C,Takeshita A,Imai K,Okumura H,Morishita Y,Usui N,Takahashi N,Fujisawa S,Shiraishi Y,Chiba K,Tanaka H,Kiyoi H,Ohnishi K,Ohtake S,Asou N,Kobayashi Y,Miyazaki Y,Miyano S,Ogawa S,Matsumura I,Nakaseko C,Naoe T C .2017 .Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia. Blood, 7(4) : e559.
Tsiatis AC,Norris-Kirby A,Rich RG,Hafez MJ,Gocke CD,Eshleman JR,Murphy KM .2010 .Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J. Mol. Diagn, 4 : 425-432.
Valeri A,Alonso-Ferrero ME,Río P,Pujol MR,Casado JA,Pérez L,Jacome A,Agirre X,Calasanz MJ,Hanenberg H,Surrallés J,Prosper F,Albella B,Bueren JA .2010 .Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: Implications in the chromosomal instability of chronic myeloid leukemia cells. PLoS, One, 5(12) : e15525.